The present study investigated whether morphine can promote regeneration and synaptic reconstruction of the terminals of injured primary afferent fibers in lamina II of the spinal cord in rats following sciatic nerve injury. Fluoride-resistant acid phosphatase (FRAP)-positive terminals in lamina II of the L4 spinal segment after sciatic nerve injury were assessed after treatment with vehicle, morphine, and naloxone plus morphine. Under the electron microscope, types I and II complex terminals of unmyelinated afferent fibers from the dorsal root, simple terminals of interneuronal axons, and terminals of descending axons at lamina II of the L4 spinal segment were documented in the different groups after injury. FRAP-positive terminals in lami...
Opioids are commonly prescribed to relieve neuropathic pain after a spinal cord injury (SCI),4 but o...
Pain after disease/damage of the nervous system is predominantly treated with opioids, but without e...
ABSTRACT Removing transient receptor potential vanilloid type 1 (TRPV1)-expressing primary afferent ...
The present study examined whether pre-injury administration of morphine can prevent partial sciatic...
Opioids are amongst the most effective and widely prescribed medications for the treatment of pain f...
The purpose of this study was to investigate the expression of c-fos in the spinal cord during the d...
[[abstract]]BACKGROUND: In this study, we examined the effects of ultra-low dose naloxone on the ant...
Peripheral nerve injury can result in long-lasting, abnormal pain states referred to as neuropathic ...
This study was undertaken to examine the antinociceptive role of mu, delta and kappa opiate receptor...
Background : Neuropathic pain which is a chronic pain state can be produced by injury of peripheral ...
Numerous studies indicate that morphine suppresses pain-evoked activities in both spinal and suprasp...
Numerous studies indicate that morphine suppresses pain-evoked activities in both spinal and suprasp...
Background: The local administration of μ-opioid receptor (MOR) agonists attenuates neuropathic pain...
Background Opioids are the gold standard for the treatment of acute pain despite serious side effec...
[[abstract]]Midbrain periaqueductal gray (PAG) and spinal cord dorsal horn are major action sites of...
Opioids are commonly prescribed to relieve neuropathic pain after a spinal cord injury (SCI),4 but o...
Pain after disease/damage of the nervous system is predominantly treated with opioids, but without e...
ABSTRACT Removing transient receptor potential vanilloid type 1 (TRPV1)-expressing primary afferent ...
The present study examined whether pre-injury administration of morphine can prevent partial sciatic...
Opioids are amongst the most effective and widely prescribed medications for the treatment of pain f...
The purpose of this study was to investigate the expression of c-fos in the spinal cord during the d...
[[abstract]]BACKGROUND: In this study, we examined the effects of ultra-low dose naloxone on the ant...
Peripheral nerve injury can result in long-lasting, abnormal pain states referred to as neuropathic ...
This study was undertaken to examine the antinociceptive role of mu, delta and kappa opiate receptor...
Background : Neuropathic pain which is a chronic pain state can be produced by injury of peripheral ...
Numerous studies indicate that morphine suppresses pain-evoked activities in both spinal and suprasp...
Numerous studies indicate that morphine suppresses pain-evoked activities in both spinal and suprasp...
Background: The local administration of μ-opioid receptor (MOR) agonists attenuates neuropathic pain...
Background Opioids are the gold standard for the treatment of acute pain despite serious side effec...
[[abstract]]Midbrain periaqueductal gray (PAG) and spinal cord dorsal horn are major action sites of...
Opioids are commonly prescribed to relieve neuropathic pain after a spinal cord injury (SCI),4 but o...
Pain after disease/damage of the nervous system is predominantly treated with opioids, but without e...
ABSTRACT Removing transient receptor potential vanilloid type 1 (TRPV1)-expressing primary afferent ...